首頁 > 市場調查報告書 > 醫療設備

生技設備

次世代定序(NGS) 自動化市場規模、佔有率和成長分析（按產品類型、應用、定序類型、最終用戶和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1897612

次世代定序(NGS) 自動化市場規模、佔有率和成長分析（按產品類型、應用、定序類型、最終用戶和地區分類）—產業預測（2026-2033 年）

NGS Automation Market Size, Share, and Growth Analysis, By Product (Workstation/Robotic Platform, Reagents & Consumables), By Application (Drug Discovery, Clinical Diagnostics), By Sequencing Type, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 242 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球次世代定序(NGS) 自動化市場規模預計在 2024 年達到 45 萬美元，在 2025 年成長到 51 萬美元，到 2033 年達到 140 萬美元，在預測期（2026-2033 年）內複合年成長率為 13.4%。

受高通量定序技術進步的推動，全球NGS自動化市場正經歷顯著成長。與傳統方法相比，這些創新技術能夠更快、更經濟高效地產生DNA和RNA，從而革新基因體學和分子生物學研究。 NGS自動化工作站透過自動化液體處理增強樣品製備，確保資料品質的一致性、可靠性和可重複性，同時降低污染風險。這種自動化最大限度地減少了人工干預，提高了NGS工作流程的效率並降低了錯誤率。藥物研發領域的應用以及主要產業參與者提供的多樣化產品進一步推動了對自動化的需求成長。然而，高昂的產品成本和召回等挑戰可能會阻礙市場擴張。總體而言，當前的市場環境為相關人員提供了動態且不斷變化的機會。

全球NGS自動化市場促進因素

全球NGS自動化市場受多種關鍵因素驅動，包括對高效自動化下一代次世代定序工作流程的需求日益成長以及癌症發病率的上升。此外，研發投入的增加和醫療費用支出的成長也進一步推動了市場成長。次世代定序技術應用範圍的不斷擴大以及旨在開發創新樣品製備方法的企業合作激增，也促進了市場的顯著擴張。預計這些因素將共同塑造NGS自動化產業的未來格局。

限制全球NGS自動化市場的因素

全球新一代定序（NGS）自動化市場面臨許多挑戰，這些挑戰可能會阻礙其成長。主要促進因素是自動化工作站的高成本。此外，監管障礙和診斷檢測缺乏標準化也是限制行業擴張的主要障礙。同時，熟練操作自動化軟體所需的專業人員也構成了額外挑戰。這些因素共同構成了一個複雜的市場環境，相關人員需要在自動化投資與滿足監管和營運要求之間尋求平衡，這可能會限制市場的成長潛力。

全球NGS自動化市場趨勢

由於自動化技術的日益普及，全球次世代定序(NGS) 自動化市場正經歷顯著成長，這些技術能夠提升 NGS 工作流程的效率和可靠性。透過簡化樣品製備流程，自動化不僅提高了資料品質和產量一致性，還提高了生產效率並降低了營運成本。此外，減少人工處理樣本和試劑可以最大限度地降低污染風險，從而創造更可靠的研究環境。隨著研究人員和實驗室不斷尋求提高工作流程效率和準確性，對先進 NGS 自動化解決方案的需求預計將持續成長，從而形成一個前景看好的市場。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Thermo Fisher Scientific Inc.（USA）
Agilent Technologies, Inc.（USA）
PerkinElmer, Inc.（USA）
Roche Holding AG（Switzerland）
Danaher Corporation（USA）
Tecan Group Ltd.（Switzerland）
Hamilton Company（USA）
Eppendorf AG（Germany）
Hudson Robotics（USA）
10x Genomics, Inc.（USA）
Bio-Rad Laboratories, Inc.（USA）
Illumina, Inc.（USA）
Becton, Dickinson and Company（BD）（USA）
Honeywell International Inc.（USA）
Siemens AG（Germany）
Abbott Laboratories（USA）
LabCorp（Laboratory Corporation of America Holdings）（USA）
Charles River Laboratories International, Inc.（USA）
Brooks Life Sciences（USA）

結論與建議

簡介目錄

Product Code: SQMIG35A2270

Global NGS Automation Market size was valued at USD 0.45 Million in 2024 and is poised to grow from USD 0.51 Million in 2025 to USD 1.4 Million by 2033, growing at a CAGR of 13.4% during the forecast period (2026-2033).

The global NGS automation market is experiencing significant growth driven by advancements in high-throughput sequencing technologies. These innovations facilitate quicker and more cost-effective generation of DNA and RNA compared to traditional methods, revolutionizing genomics and molecular biology research. NGS automation workstations enhance library preparation through automated liquid handling, ensuring consistent, reliable, and reproducible data quality while reducing contamination risks. This automation minimizes manual intervention, increasing productivity and lowering error rates in the NGS workflow. The rising demand for automation is further propelled by its applications in drug development and a diverse range of offerings from major industry players. However, challenges such as high product costs and recalls may hinder market expansion. Overall, the landscape presents a dynamic and evolving opportunity for stakeholders.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global NGS Automation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global NGS Automation Market Segments Analysis

Global NGS Automation Market is segmented by Product, Application, Sequencing Type, End User and region. Based on Product, the market is segmented into Workstation/Robotic Platform and Reagents & Consumables. Based on Application, the market is segmented into Drug Discovery, Clinical Diagnostics, Oncology, Infectious Diseases, Reproductive Health, Other Clinical Diagnostics and Other Applications. Based on Sequencing Type, the market is segmented into Whole Genome Sequencing, Whole Exome Sequencing, Targeted Genome Sequencing and Others. Based on End User, the market is segmented into Hospitals & Diagnostic Laboratories,Pharmaceuticaland Biotechnology Companies, Academic Research Institutes and Others End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global NGS Automation Market

The Global NGS Automation market is driven by several key factors, including the growing demand for streamlined automation within next-generation sequencing workflows, alongside the increasing incidence of cancer. Additionally, rising investments in research and development, in conjunction with escalating healthcare expenditures, are further propelling market growth. The broadening applications of next-generation sequencing technology, coupled with a surge in collaborations among companies aimed at developing innovative library preparation methods, are also contributing to the market's significant expansion. Together, these elements are set to shape the future landscape of the NGS automation sector.

Restraints in the Global NGS Automation Market

The Global NGS Automation market faces notable challenges that may impede its growth, primarily stemming from the elevated costs associated with automation workstations. Additionally, regulatory hurdles and the lack of standardization in diagnostic testing present significant obstacles to industry expansion. Furthermore, the necessity for a workforce equipped with specialized skills to effectively operate automation software adds another layer of difficulty. These factors collectively contribute to a complex environment that may restrain the market's potential for growth, as stakeholders navigate the balance between investing in automation and addressing regulatory and operational requirements.

Market Trends of the Global NGS Automation Market

The Global NGS Automation market is experiencing significant growth due to the increasing adoption of automation technologies that enhance the efficiency and reliability of next-generation sequencing (NGS) workflows. By streamlining library preparation processes, automation not only improves data quality and yield consistency but also boosts productivity while simultaneously reducing operational costs. Furthermore, the diminished manual handling of samples and reagents minimizes contamination risks, fostering a more reliable research environment. As researchers and laboratories seek to improve workflow efficiency and accuracy, the demand for advanced NGS automation solutions is set to escalate, shaping a promising market landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global NGS Automation Market Size by Product & CAGR (2026-2033)

Market Overview
Workstation/Robotic Platform
Reagents & Consumables

Global NGS Automation Market Size by Application & CAGR (2026-2033)

Market Overview
Drug Discovery
Clinical Diagnostics
Oncology
Infectious Diseases
Reproductive Health
Other Clinical Diagnostics
Other Applications

Global NGS Automation Market Size by Sequencing Type & CAGR (2026-2033)

Market Overview
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Genome Sequencing
Others

Global NGS Automation Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals & Diagnostic Laboratories
Pharmaceutical and Biotechnology Companies
Academic Research Institutes
Others End Users

Global NGS Automation Market Size & CAGR (2026-2033)

North America (Product, Application, Sequencing Type, End User)
- US
- Canada
Europe (Product, Application, Sequencing Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Application, Sequencing Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Application, Sequencing Type, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application, Sequencing Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tecan Group Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamilton Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eppendorf AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hudson Robotics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
10x Genomics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Honeywell International Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LabCorp (Laboratory Corporation of America Holdings) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Brooks Life Sciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments